Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2013-05-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on Plantar Pressure Distribution, Gait Balance and Lower Back Pain in Pregnant Women
NCT06240156
A Test of Efficacy and Foot Position Alteration in Patients Wearing Good Feet Arch Supports for the Treatment of Pain
NCT07103070
Biomechanical and Viscoelastic Properties of Plantar Fascia in Pregnant Women-Pilot Study
NCT05318001
Validation of Plantar Orthoses for Abnormal Plantar Arch Using a New Non-invasive Clinical Imaging System
NCT05163418
Flexible Footwear and Insole in Heel Pain
NCT03040557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
More important than the foot changes that have been reported during pregnancy is the issue that these changes persist following completion of pregnancy. In a self-report study, we found a dose-response relationship between the number of pregnancies and the frequency of a report of a permanent change in foot size in women age 18-45.\[37\] We then conducted a longitudinal study to determine whether arch height loss both occurs and persists postpartum. Sixty women in their first trimester of pregnancy were enrolled and arch height and function were measured at baseline and approximately 19 weeks postpartum. There was a significant decrease in arch height and arch rigidity index at follow-up, with concomitant increases in foot length and arch drop. This study revealed that, not only was pregnancy associated with a permanent loss of arch height, but also the first pregnancy appeared to be the most significant with a reduction in arch rigidity (p\<0.0001) and increases in foot length (p\<0.0001), arch drop (p=0.0019) and center of pressure excursion during gait (p=0.0019). These changes in the feet could contribute to the increased risk for subsequent musculoskeletal disorders.
Arch Height Loss Leads to Adverse Biomechanical Changes at Other Joints Consideration of the effect of foot structure on forces and torques at other joints in the lower limb and spine as well as the need for energy generation and absorption by associated soft-tissue structures illustrates the importance of these potential changes. With each step, a series of events occurs that elicits biomechanical effects and compensations throughout the lower limb kinetic chain, in which movement at each joint influences movement at other joints in the chain.\[38\] Disruption of the complex interactions between skeletal, musculotendinous and ligamentous structures through loss of arch height may predispose to painful musculoskeletal conditions.\[39-43\] As the initial link in body loading during stance and movement, the feet are "where the rubber hits the road." The arch dynamically deforms to distribute the force, thereby absorbing the rapid impulse of loading. Changes in foot biomechanics that occur with changes in the foot structure alter the normal control of forces propagating from the foot to more proximal lower limb joints and the spine,\[44\] and contribute to pain in the feet, knees, hips,\[41-43\] and low back.
Possibly the most common cause of such changes in biomechanics is the loss of arch height. Excessive pronation strains the supporting structures of the foot and tendons that cross the ankle, leads to impaired balance,\[45\] can strain passive stabilizers such as the Achilles tendon, iliotibial band,\[46\] and anterior cruciate ligament,\[47\] and can contribute to permanent impairments in the soft tissue structures in the lower limbs.\[47, 48\] Thus, excessive pronation has been implicated in numerous musculoskeletal complaints, through pathologically re-distributing the ground reaction force over the foot,\[49\] changing patellar tracking in the femoral trochlea,\[50\] changing the angle of pull of muscular stabilizers in the lower limbs, and inducing a functional leg length inequality that alters hip and spine loading.\[1\] Therefore, there is a need to address this gap in knowledge to inform preventive interventions if there are musculoskeletal sequellae.
Biomechanical Changes Contribute to Musculoskeletal Disease Risk As mentioned previously, the permanent loss of arch height that occurs in about 40% of women with pregnancy leads to excessive pronation of the foot. This foot posture causes increased rotation of the tibia\[51\] and is communicated across the knee. These torques, in turn, may increase compressive and shear stress on the medial tibiofemoral and lateral patellofemoral compartments of the knee. This is important in light of previous work demonstrating that elevated contact stress is predictive of development of incident symptomatic knee osteoarthritis,\[52\] and the relative risk for knee replacement surgery increases with the number of pregnancies carried.\[53\] Closing Knowledge Gaps May Attenuate Musculoskeletal Disease Risk in Women In consideration of the evidence to date that pregnancy leads to a drop in the arch and that loss of the arch may contribute to musculoskeletal disease and disablement, there is a compelling rationale to characterize whether use of arch supports during pregnancy can prevent these adverse changes in foot structure during pregnancy. The proposed study will randomize women to either an arch-supportive insole or a control group(that does not wear insoles) and will measure static and dynamic arch structure in the early part of the first trimester and then again 8 weeks postpartum. Successful completion will inform the extent to which loss of arch height with pregnancy can be ameliorated using a conservative physical medicine intervention. This line of research holds great potential to inform preventive interventions to reduce the disproportionate risk for musculoskeletal disease and disability borne by women.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual
Participants who are not randomized to the fitted insole intervention
No interventions assigned to this group
Insole
Participants randomized to use of a custom-molded insole during pregnancy
Insole
Custom-molded arch-supporting insole
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insole
Custom-molded arch-supporting insole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18 and 40
Exclusion Criteria
* inflammatory joint or muscle problems such as rheumatoid or psoriatic arthritis
* diabetes
* collagen disorder such as Marfan Syndrome, Ehlers-Danlos Syndrome, Mixed Connective Tissue Disease, or Osteogenesis Imperfecta
* cannot walk without any assistance
* surgeries or have another medical condition that may affect their walking ability
* flat feet (absence of a longitudinal arch)
* inability to return for the follow-up visit 2 months after delivery
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation for Physical Medicine and Rehabilitation
OTHER
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Neil A Segal
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neil A Segal, MD
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201209787
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.